The neuroscience of advanced meditation: The promise of third wave meditation research
Neuron · 2026-05 · 114 (9) · 1545-1550
DOI: 10.1016/j.neuron.2026.02.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuron, 2026-05. Verfasst von Matthew D Sacchet und 1 weiteren Autor:innen. Beteiligte Einrichtung: Meditation Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: m…. Hauptthemen laut MEDLINE: Meditation, Neurosciences, Brain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Third wave meditation research-the study of advanced meditation-investigates states, stages, and endpoints of meditation practice that emerge with increasing mastery. We review current neuroscientific progress, outline future research directions, and highlight far-reaching implications of this emerging scientific subfield.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Meditation Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: meditationadministration@mgh.harvard.edu.
- Meditation Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Zitieren
APA
Sacchet, M. D., & Lieberman, J. M. (2026). The neuroscience of advanced meditation: The promise of third wave meditation research. Neuron, 114(9), 1545-1550. https://doi.org/10.1016/j.neuron.2026.02.009
Vancouver
Sacchet MD, Lieberman JM. The neuroscience of advanced meditation: The promise of third wave meditation research. Neuron. 2026;114(9):1545-1550. doi:10.1016/j.neuron.2026.02.009
BibTeX
@article{Sacchet2026,
author = {Sacchet, Matthew D and Lieberman, Jonathan M},
title = {The neuroscience of advanced meditation: The promise of third wave meditation research},
journal = {Neuron},
year = {2026},
volume = {114},
number = {9},
pages = {1545--1550},
doi = {10.1016/j.neuron.2026.02.009}
}
EUVIMED